Director/PDMR Shareholding

GlaxoSmithKline PLC 16 July 2007 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 16 July 2007 of an increase in their notional interests in Ordinary Shares at a price of £14.41 per share and Ordinary Share ADRs at a price of $57.68 per ADR following the notional re-investment of the dividend paid to shareholders on 12 July 2007. Ordinary Shares ADRs Dr JP Garnier 5,686.35 Mr J S Heslop 1873.73 Mr W C Louv 300.06 Dr M M Slaoui 334.63 575.01 Mrs C E Bruck Slaoui 29.14 13.08 Mr R M Bondy 1,993.89 Mr J M Clarke 1542.16 Mr M Dunoyer 750.95 Dr R G Greig 647.61 Mr D Learmouth 274.81 Mr D J Phelan 997.31 Dr D Pulman 647.61 Mr D M Stout 2,375.48 Mr C Viehbacher 1,030.65 Mr A P Witty 2,060.51 The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to transactions notified in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b). S M Bicknell Company Secretary 16 July 2007 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings